Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 1
1998 3
1999 1
2000 3
2001 1
2002 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
ADC Target Profiling in NSCLC: Generalizable AI Separates TROP-2 and cMET Phenotypes.
Anders P, Sextro M, Lingelbach K, Standvoss K, Pandhe S, Ghosh S, Böhm C, Tietz S, Krupar R, Tharun L, Eich ML, Ribbat-Idel J, Ramberger E, Liang X, Aumiller V, Merkelbach-Bruse S, Quaas A, Frost N, Schlachtenberger G, Heldwein M, Keilholz U, Hekmat K, Rückert JC, Büttner R, Grohe C, Horst D, Alber M, Ruff L, Klauschen F, Dernbach G, Seegerer P, Schallenberg S. Anders P, et al. Among authors: sextro m. Clin Cancer Res. 2026 Jul 1;32(13):2765-2786. doi: 10.1158/1078-0432.CCR-25-4513. Clin Cancer Res. 2026. PMID: 41945491 Free PMC article.
European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.
Anagnostopoulos I, Hansmann ML, Franssila K, Harris M, Harris NL, Jaffe ES, Han J, van Krieken JM, Poppema S, Marafioti T, Franklin J, Sextro M, Diehl V, Stein H. Anagnostopoulos I, et al. Among authors: sextro m. Blood. 2000 Sep 1;96(5):1889-99. Blood. 2000. PMID: 10961891 Free article.
Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.
Loeffler M, Brosteanu O, Hasenclever D, Sextro M, Assouline D, Bartolucci AA, Cassileth PA, Crowther D, Diehl V, Fisher RI, Hoppe RT, Jacobs P, Pater JL, Pavlovsky S, Thompson E, Wiernik P. Loeffler M, et al. Among authors: sextro m. J Clin Oncol. 1998 Mar;16(3):818-29. doi: 10.1200/JCO.1998.16.3.818. J Clin Oncol. 1998. PMID: 9508162
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
Diehl V, Franklin J, Hasenclever D, Tesch H, Pfreundschuh M, Lathan B, Paulus U, Sieber M, Rüffer JU, Sextro M, Engert A, Wolf J, Hermann R, Holmer L, Stappert-Jahn U, Winnerlein-Trump E, Wulf G, Krause S, Glunz A, von Kalle K, Bischoff H, Haedicke C, Dühmke E, Georgii A, Loeffler M. Diehl V, et al. Among authors: sextro m. Ann Oncol. 1998;9 Suppl 5:S67-71. doi: 10.1093/annonc/9.suppl_5.s67. Ann Oncol. 1998. PMID: 9926240 Review.
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.
Schmitz N, Pfistner B, Sextro M, Sieber M, Carella AM, Haenel M, Boissevain F, Zschaber R, Müller P, Kirchner H, Lohri A, Decker S, Koch B, Hasenclever D, Goldstone AH, Diehl V; German Hodgkin's Lymphoma Study Group; Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Schmitz N, et al. Among authors: sextro m. Lancet. 2002 Jun 15;359(9323):2065-71. doi: 10.1016/S0140-6736(02)08938-9. Lancet. 2002. PMID: 12086759 Clinical Trial.
Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF.
Pfreundschuh M, Hasenclever D, Loeffler M, Ehninger G, Schmitz N, Kirchner H, Koch P, Lathan B, Rueffer U, Sextro M, Franklin J, Tesch H, Diehl V; German Hodgkin's Lymphoma Study Group. Pfreundschuh M, et al. Among authors: sextro m. Ann Oncol. 2001 Apr;12(4):471-7. doi: 10.1023/a:1011108722666. Ann Oncol. 2001. PMID: 11398878 Free article. Clinical Trial.
Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
Diehl V, Sextro M, Franklin J, Hansmann ML, Harris N, Jaffe E, Poppema S, Harris M, Franssila K, van Krieken J, Marafioti T, Anagnostopoulos I, Stein H. Diehl V, et al. Among authors: sextro m. J Clin Oncol. 1999 Mar;17(3):776-83. doi: 10.1200/JCO.1999.17.3.776. J Clin Oncol. 1999. PMID: 10071266 Clinical Trial.
13 results